Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026
Go back to Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026| (NASDAQ: DTIL) | Delayed: 7.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.08 | 52 Week High | $ | |||
| Open | $7.08 | 52 Week Low | $ | |||
| Day High | $7.08 | P/E | N/A | |||
| Day Low | $7.08 | EPS | $ | |||
| Volume | 41 | |||||

